Investor Relations

Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop a safe and clinically backed treatment. Bringing new treatments to market will help improve patients' treatment options and lives.

Investor Relations

Copyright West LLC. Minimum 15 minutes delayed.

News Releases
May 14, 2019
electroCore Announces First Quarter 2019 Financial Results
Continues to deliver sequential growth in covered lives, prescribing physicians and FSS facilities  Company to host conference call and webcast today, May 14 , at 4:30pm ET BASKING RIDGE, N.J. , May 14, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic

Investor Contact

Investor Relations

Hans Vitzthum, LifeSci Advisors
investors@electrocore.com